Huiying Zhi

Title: Huiying Zhi: Innovator in Platelet Research

Introduction

Huiying Zhi is a prominent inventor based in Brookfield, WI (US), known for her significant contributions to the field of platelet research. With a total of 2 patents, she has made remarkable strides in understanding and developing innovative solutions for fetal and neonatal alloimmune thrombocytopenia.

Latest Patents

Huiying Zhi's latest patents include a murine model of fetal/neonatal alloimmune thrombocytopenia. This patent describes a transgenic mouse comprising T30A, S32P, Q33L, N39D, and M470Q mutations in GPIIIa, along with methods for creating and utilizing this transgenic mouse to screen test compounds. Another notable patent is a method to bioengineer designer platelets using gene editing and stem cell methodologies. This patent outlines methods for creating cells that express specific platelet alloantigens by combining gene editing techniques with cell culture differentiation or expansion techniques using pluripotent cells.

Career Highlights

Throughout her career, Huiying Zhi has worked with various organizations, including the Versiti Blood Research Institute Foundation, Inc. Her work has focused on advancing the understanding of platelet biology and developing innovative therapeutic approaches.

Collaborations

Huiying has collaborated with notable colleagues such as Peter J. Newman and Sridhar Rao, contributing to the advancement of research in her field.

Conclusion

Huiying Zhi's innovative work in platelet research and her patented methodologies highlight her significant impact on the scientific community. Her contributions continue to pave the way for advancements in medical research and treatment options.